Piper Sandler Keeps Their Hold Rating on Medtronic (MDT)
Piper Sandler analyst Matthew O’Brien reiterated a Hold rating on Medtronic (MDT – Research Report) today. The company’s shares opened today at ...
Piper Sandler: Mid-Market But Better Indexed To Lax FTC (Rating Upgrade)
Piper Sandler Companies is gaining traction with a recovering market. Find out why PIPR stock is becoming an attractive ...
Piper initiates on soda stocks; Pepsi, Coca-Cola ‘overweight,’ Dr Pepper ‘neutral'
Piper Sandler initiated coverage on soda stocks, rating PepsiCo (NASDAQ:PEP), Coca-Cola (NYSE:KO) “overweight,” and Neutral on Keurig Dr Pepper (NASDAQ:KDP).
Coinbase price target raised to $285 from $245 at Piper Sandler
Piper Sandler raised the firm’s price target on Coinbase (COIN) to $285 from $245 and keeps a Neutral rating on the shares as part of an ...
Coca-Cola and PepsiCo land bull ratings at Piper Sandler
Piper Sandler dipped into the beverage sector on Tuesday by issuing new Overweight ratings on Coca-Cola (NYSE:KO) and PepsiCo ...
Yahoo Finance3d
Piper Sandler Companies (PIPR)
LONDON, January 06, 2025--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Paul Leece, Jeremi Martin and Daniel Allmomen to its energy ...
Kenvue stock still has 'ample room': Piper Sandler
Despite recent share appreciation, Piper Sandler believes there is still significant upside for Kenvue. “Though shares have ...
Piper Sandler Companies (NYSE:PIPR) Cut to “Neutral” at The Goldman Sachs Group
Piper Sandler Companies (NYSE:PIPR – Get Free Report) was downgraded by equities research analysts at The Goldman Sachs Group from a “buy” rating to a “neutral” rating in a report issued on ...
Cloudflare, Nutanix, Twilio among top automation software stocks for 2025: Piper Sandler
Nutanix (NTNX) and Twilio (TWLO) are among Piper Sandler's favorite cloud automation software stocks for 2025. Read for ...
Nasdaq1mon
Poseida Therapeutics downgraded to Neutral from Overweight at Piper Sandler
Piper Sandler downgraded Poseida Therapeutics (PSTX) to Neutral from Overweight with an unchanged price target of $10 following Roche’s announced acquisition for $9 per share in cash and $4 per ...
Hosted on MSN16h
Piper Sandler Initiates Coverage of Norwood Financial (NWFL) with Neutral Recommendation
Fintel reports that on January 8, 2025, Piper Sandler initiated coverage of Norwood Financial (NasdaqGM:NWFL) with a Neutral ...